In the last trading session, 2.21 million Compugen Ltd (NASDAQ:CGEN) shares changed hands as the company’s beta touched 2.57. With the company’s per share price at $2.00 changed hands at $0.01 or 0.50% during last session, the market valuation stood at $179.08M. CGEN’s last price was a discount, traded about -51.5% off its 52-week high of $3.03. The share price had its 52-week low at $1.35, which suggests the last value was 32.5% up since then. When we look at Compugen Ltd’s average trading volume, we note the 10-day average is 0.87 million shares, with the 3-month average coming to 435.13K.
Analysts gave the Compugen Ltd (CGEN) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended CGEN as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.
Compugen Ltd (NASDAQ:CGEN) trade information
Instantly CGEN was in green as seen at the end of in last trading. With action 25.00%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 30.72%, with the 5-day performance at 25.00% in the green. However, in the 30-day time frame, Compugen Ltd (NASDAQ:CGEN) is 25.00% up. Looking at the short shares, we see there were 1.27 million shares sold at short interest cover period of 6.42 days.
The consensus price target for the stock as assigned by Wall Street analysts is 4, meaning bulls need an upside of 50.0% from its current market value. According to analyst projections, CGEN’s forecast low is 4 with 4 as the target high. To hit the forecast high, the stock’s price needs a -100.0% plunge from its current level, while the stock would need to soar -100.0% for it to hit the projected low.
Compugen Ltd (CGEN) estimates and forecasts
Data shows that the Compugen Ltd share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 4.71% over the past 6 months, a 119.05% in annual growth rate that is considerably higher than the industry average of 16.70%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 12.14%. The 2025 estimates are for Compugen Ltd earnings to increase by 66.67%.
CGEN Dividends
Compugen Ltd is expected to release its next quarterly earnings report in February.
TAYLOR FRIGON CAPITAL MANAGEMENT LLC holds the second largest percentage of outstanding shares, with 1.4685% or 1.31 million shares worth $2.21 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Delaware Group Equity Fds IV-Delaware Healthcare Fund and PFS Funds-Taylor Frigon Core Growth Fund . With 1.02 shares estimated at $2.04 million under it, the former controlled 1.14% of total outstanding shares. On the other hand, PFS Funds-Taylor Frigon Core Growth Fund held about 0.27% of the shares, roughly 242.97 shares worth around $0.49 million.
